In 2013 Mesoblast acquired Prochymal for $50m. The company hasn't really added any value to that, although it's spent a huge amount on failed trials, and is in hock for $90m with the IP pledged as security. So to me a market cap of $1B looks like a Ponzi scheme on steroids, if such a thing is possible.
ODAC August 2020 event materials, page-40
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |